Voyager Therapeutics, Inc. VYGR
1.82 USD +0.03 +1.97%
As of Nov 3, 2:41 PM ET
- YTD
- -53.82%
- 1 year
- -60.46%
- Open
- 1.80
- Prev close
- 1.78
- Mkt cap
- 111.89M
- Vol
- 488.15K
- Avg vol
- 670.93K
- EPS
- -1.81
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.79
- High
- 1.87
- Forward P/E
- -3.41
- Beta
- 0.89
- Short ratio
- 4.44
- Inst. own
- 65.52%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.52
- 200-d avg
- 7.56
- 1y target
- 17.10
5D chart
Chart tools
Chart is warming up
The five-day price history for VYGR has not been loaded yet. Try again in a moment.
Altman Z-Score
-2.97 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
P/E -1.9×
P/S 5.7×
P/B 1.2×
P/FCF -1.7×
EV/EBITDA -1.7×
EV/Sales 5.0×
FCF Yield -58.6%
Gross Margin -227.6%
Operating Margin -326.6%
Net Margin -296.5%
ROE -61.1%
ROIC -56.4%
ROA -47.5%
Revenue -49.5%
Operating Income -58.3%
EPS (diluted) -80.5%
Free Cash Flow -617.2%
Current Ratio 7.6×
Quick Ratio 7.6×
Debt / Equity 0.2×
Net Debt / EBITDA 0.2×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2025-12-31